(Q36089136)

12 August 2017

PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV. (English)

1 reference

12 August 2017

1 reference

Diwakar Davar

1

1 reference

12 August 2017

Melissa Wilson

series ordinal

2

1 reference

12 August 2017

Chelsea Pruckner

series ordinal

3

1 reference

12 August 2017

John M Kirkwood

series ordinal

4

1 reference

12 August 2017

10 September 2015

1 reference

Case Reports in Oncological Medicine

12 August 2017

1 reference

12 August 2017

2015

1 reference

12 August 2017

737389

1 reference

Creative Commons Attribution 3.0 Unported

12 August 2017

start time

1 January 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravis

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4581502

21 October 2018

Identifiers

DOI

10.1155/2015/737389

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26448890

1 reference